Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan Jinruibao Pharmaceutical Technology is a pharmaceutical research and development firm based in Haikou, China. The company specializes in the technical development of generic drugs, pharmaceutical intermediates, and chemical raw materials. It provides a range of services including formulation optimization, process chemistry, and regulatory compliance support for consistency evaluations. Jinruibao serves as a strategic R&D partner for various Chinese pharmaceutical manufacturers, focusing on high-demand therapeutic areas such as cardiovascular and metabolic diseases. The company leverages the policy advantages of the Hainan Free Trade Port to facilitate technology transfer and pharmaceutical innovation. Its core expertise lies in small molecule synthesis and the development of complex dosage forms for the domestic market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hainan Jinruibao Pharmaceutical Technology.